---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-000393"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T20:08:19.989891+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals to appoint Amy Mahery as independent director upon financing close

## Summary
- Amy Mahery appointed as independent Board member effective upon completion of Company's financing.
- She will not serve on any Board committees initially.
- Compensation will follow standard non-employee director program as previously disclosed.
- No other changes to Board or management.

## SEC filing metadata
- accession: 0001683168-24-000393
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824000393/0001683168-24-000393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824000393/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-000393
- JSON: https://secwatch.observer/filing/0001683168-24-000393.json
- Plain text: https://secwatch.observer/filing/0001683168-24-000393.txt

## Key facts
- Executive change
  Amy Mahery was appointed as Director at CNS Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: On January 17, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) agreed to appoint Amy Mahery as an independent member of the Company’s Board of Directors effective upon the completion of the Company’s financing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1729427/000168316824000393/0001683168-24-000393-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.